Literature DB >> 3498361

Haemophilus influenzae non-type b infections in children.

J R Gilsdorf.   

Abstract

During a four-year surveillance period in a tertiary care children's hospital, nine children experienced 11 episodes of Haemophilus influenzae non-type b invasive infections, representing 9% of all invasive H influenzae infections. Of these nine children, two had lymphoproliferative disorders; one had immunoglobulin subclass deficiency; one had severe congenital heart disease, with chronic heart failure; two had cerebrospinal fluid leaks; and two were premature neonates whose mothers had prolonged rupture of amniotic membranes. Only one child had no evidence of an underlying condition that might predispose him to infection with these ordinarily nonpathogenic organisms. Three of the isolates were serotype f, one was serotype e, and the remaining seven were nontypable, with types a through f antisera. Thus, the majority of children experiencing invasive H influenzae non-type b infections appear to have a predisposing medical condition. To aid in detecting these unusual infections, all H influenzae isolates from otherwise sterile body sites should be serotyped, and those children with non-type b isolates should be evaluated for a possible predisposing underlying illness.

Entities:  

Mesh:

Year:  1987        PMID: 3498361     DOI: 10.1001/archpedi.141.10.1063

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  12 in total

1.  Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.

Authors:  S V Hetherington; C C Patrick; E J Hansen
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

2.  Relationship of health-related variables to levels of anti-polyribosylribitol phosphate antibodies in adults.

Authors:  W M McDonnell; J R Gilsdorf; J B Kent; J N Sheagren
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

3.  Haemophilus influenzae meningitis in an elderly patient despite treatment with oral cefuroxime.

Authors:  R Smith; R W Prescott; F Ahmad
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

4.  Comparative analysis of Haemophilus influenzae hifA (pilin) genes.

Authors:  D L Clemans; C F Marrs; M Patel; M Duncan; J R Gilsdorf
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

Authors:  Joshua M O'Neill; Joseph W St Geme; David Cutter; Elisabeth E Adderson; Juliana Anyanwu; Richard F Jacobs; Gordon E Schutze
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Comparison of hemagglutinating pili of Haemophilus influenzae type b with similar structures of nontypeable H. influenzae.

Authors:  J R Gilsdorf; H Y Chang; K W McCrea; L O Bakaletz
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Haemophilus influenzae type f meningitis in a previously healthy boy.

Authors:  Andreas Ronit; Ronan M G Berg; Helle Bruunsgaard; Ronni R Plovsing
Journal:  BMJ Case Rep       Date:  2013-05-02

8.  Invasive Haemophilus influenzae Disease, Europe, 1996-2006.

Authors:  Shamez Ladhani; Mary P E Slack; Paul T Heath; Anne von Gottberg; Manosree Chandra; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

9.  Invasive Haemophilus influenzae serotype e and f disease, England and Wales.

Authors:  Shamez N Ladhani; Sarah Collins; Anna Vickers; David J Litt; Carina Crawford; Mary E Ramsay; Mary P E Slack
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

10.  Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005.

Authors:  Michael G Bruce; Shelley L Deeks; Tammy Zulz; Christine Navarro; Carolina Palacios; Cheryl Case; Colleen Hemsley; Tom Hennessy; Andre Corriveau; Bryce Larke; Isaac Sobel; Marguerite Lovgren; Carolynn Debyle; Raymond Tsang; Alan J Parkinson
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.